Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Low-Concentration Atropine Eye Drops for Myopia Progression

Low-Concentration Atropine Eye Drops for Myopia Progression Downloaded from http://journals.lww.com/apjoo by BhDMf5ePHKbH4TTImqenVA5KvPVPZ0P5BEgU+IUTEfzO/GUWifn2IfwcEVVH9SSn on 06/05/2020 REVIEW ARTICLE Fen Fen Li, MD and Jason C. Yam, FCOphthHK, FRCSEd myopic by 2050. In mainland China, the 3-year incidence of Purpose: Atropine eye drops is an emerging therapy for myopia control. myopia (SE 0.5 D) in school-aged children aged 6 to 7 years This article reviews the recent clinical trials to provide a better under- was 39.5%. In urban areas, such as Guangzhou, the prevalence was standing of the use of atropine eye drops on myopia progression. 5.7% in 5-year olds, 30.1% in 10-year olds, and up to 78.4% in 15- Methods: All randomized clinical trials of atropine eye drops for myopia year olds, respectively. In rural areas, such as Yangxi and Shunyi, progression in the literatures were reviewed. the prevalence was zero in 5-year olds, 36.8% in 13-year olds, Results: Atropine eye drops 1% conferred the strongest efficacy on 8,9 43.0% in 15-year olds, and 53.9% in 17-year olds, respectively. myopia control. However, its use was limited by the side effects of Prevalence of myopic kindergarten children was 0.8% in 4-year old, blurred near vision and photophobia. ATOM 2 study evaluated 0.5%, 1.3% in 5-year old, and 3.7% in http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png The Asia-Pacific Journal of Ophthalmology Wolters Kluwer Health

Low-Concentration Atropine Eye Drops for Myopia Progression

Loading next page...
 
/lp/wolters-kluwer-health/low-concentration-atropine-eye-drops-for-myopia-progression-y1UhmBi7fV
Publisher
Wolters Kluwer Health
ISSN
2162-0989
eISSN
2475-5028
DOI
10.1097/APO.0000000000000256
Publisher site
See Article on Publisher Site

Abstract

Downloaded from http://journals.lww.com/apjoo by BhDMf5ePHKbH4TTImqenVA5KvPVPZ0P5BEgU+IUTEfzO/GUWifn2IfwcEVVH9SSn on 06/05/2020 REVIEW ARTICLE Fen Fen Li, MD and Jason C. Yam, FCOphthHK, FRCSEd myopic by 2050. In mainland China, the 3-year incidence of Purpose: Atropine eye drops is an emerging therapy for myopia control. myopia (SE 0.5 D) in school-aged children aged 6 to 7 years This article reviews the recent clinical trials to provide a better under- was 39.5%. In urban areas, such as Guangzhou, the prevalence was standing of the use of atropine eye drops on myopia progression. 5.7% in 5-year olds, 30.1% in 10-year olds, and up to 78.4% in 15- Methods: All randomized clinical trials of atropine eye drops for myopia year olds, respectively. In rural areas, such as Yangxi and Shunyi, progression in the literatures were reviewed. the prevalence was zero in 5-year olds, 36.8% in 13-year olds, Results: Atropine eye drops 1% conferred the strongest efficacy on 8,9 43.0% in 15-year olds, and 53.9% in 17-year olds, respectively. myopia control. However, its use was limited by the side effects of Prevalence of myopic kindergarten children was 0.8% in 4-year old, blurred near vision and photophobia. ATOM 2 study evaluated 0.5%, 1.3% in 5-year old, and 3.7% in

Journal

The Asia-Pacific Journal of OphthalmologyWolters Kluwer Health

Published: Sep 1, 2019

There are no references for this article.